Inherited Mutations in Breast Cancer Genes—Risk and Response
✍ Scribed by Andrew Y. Shuen; William D. Foulkes
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 478 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1083-3021
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mutations in the __NBS1__ gene have been identified as disease‐causing mutations in patients with Nijmegen Breakage Syndrome (NBS), but their clinical impact on breast cancer susceptibility has remained uncertain. We determined the frequency of 2 NBS mutations, 657del5 and R215W, in two
The peripheral myelin protein 22 gene (PMP22), the myelin protein zero gene (MPZ, P0), and the connexin 32 gene (Cx32, GJB1) code for membrane proteins expressed in Schwann cells of the peripheral nervous system (PNS). The early growth response 2 gene (EGR2) encodes a transcription factor that may c
## Abstract Polymorphisms in phase I and phase II enzymes may enhance the occurrence of mutations at critical tumor suppressor genes, such as __p53__, and increase breast cancer risk by either increasing the activation or detoxification of carcinogens and/or endogenous estrogens. We analyzed polymo